These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34158021)

  • 1. Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study.
    McKeigue PM; McAllister DA; Caldwell D; Gribben C; Bishop J; McGurnaghan S; Armstrong M; Delvaux J; Colville S; Hutchinson S; Robertson C; Lone N; McMenamin J; Goldberg D; Colhoun HM
    BMC Med; 2021 Jun; 19(1):149. PubMed ID: 34158021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    McKeigue PM; Weir A; Bishop J; McGurnaghan SJ; Kennedy S; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Ramsay C; Hutchinson S; Colhoun HM;
    PLoS Med; 2020 Oct; 17(10):e1003374. PubMed ID: 33079969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.
    McKeigue PM; McAllister DA; Hutchinson SJ; Robertson C; Stockton D; Colhoun HM
    Lancet Respir Med; 2022 Jun; 10(6):566-572. PubMed ID: 35227416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hospital admission with covid-19 among teachers compared with healthcare workers and other adults of working age in Scotland, March 2020 to July 2021: population based case-control study.
    Fenton L; Gribben C; Caldwell D; Colville S; Bishop J; Reid M; White J; Campbell M; Hutchinson S; Robertson C; Colhoun HM; Wood R; McKeigue PM; McAllister DA
    BMJ; 2021 Sep; 374():n2060. PubMed ID: 34470747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of severe COVID-19 to polypharmacy and prescribing of psychotropic drugs: the REACT-SCOT case-control study.
    McKeigue PM; Kennedy S; Weir A; Bishop J; McGurnaghan SJ; McAllister D; Robertson C; Wood R; Lone N; Murray J; Caparrotta TM; Smith-Palmer A; Goldberg D; McMenamin J; Guthrie B; Hutchinson S; Colhoun HM;
    BMC Med; 2021 Feb; 19(1):51. PubMed ID: 33612113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022.
    Galmiche S; Charmet T; Rakover A; Schaeffer L; Chény O; von Platen C; Omar F; David C; Mailles A; Carrat F; Fontanet A
    JAMA Netw Open; 2023 Sep; 6(9):e2334084. PubMed ID: 37713194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMPACT-Scot 2 report on COVID-19 in hip fracture patients.
    Hall AJ; Clement ND; MacLullich AMJ; White TO; Duckworth AD
    Bone Joint J; 2021 May; 103-B(5):888-897. PubMed ID: 33487012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study.
    Simpson CR; Robertson C; Vasileiou E; Moore E; McCowan C; Agrawal U; Stagg HR; Docherty A; Mulholland R; Murray JLK; Ritchie LD; McMenamin J; Sheikh A
    Lancet Digit Health; 2021 Aug; 3(8):e517-e525. PubMed ID: 34238721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
    Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ
    Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study.
    Florentino PTV; Millington T; Cerqueira-Silva T; Robertson C; de Araújo Oliveira V; Júnior JBS; Alves FJO; Penna GO; Vital Katikireddi S; Boaventura VS; Werneck GL; Pearce N; McCowan C; Sullivan C; Agrawal U; Grange Z; Ritchie LD; Simpson CR; Sheikh A; Barreto ML; Rudan I; Barral-Netto M; Paixão ES
    Lancet Infect Dis; 2022 Nov; 22(11):1577-1586. PubMed ID: 35952702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.
    McGurnaghan SJ; Weir A; Bishop J; Kennedy S; Blackbourn LAK; McAllister DA; Hutchinson S; Caparrotta TM; Mellor J; Jeyam A; O'Reilly JE; Wild SH; Hatam S; Höhn A; Colombo M; Robertson C; Lone N; Murray J; Butterly E; Petrie J; Kennon B; McCrimmon R; Lindsay R; Pearson E; Sattar N; McKnight J; Philip S; Collier A; McMenamin J; Smith-Palmer A; Goldberg D; McKeigue PM; Colhoun HM; ;
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):82-93. PubMed ID: 33357491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of Shielding Behavior During the COVID-19 Pandemic and Associations With Well-being Among National Health Service Patients: Longitudinal Observational Study.
    Bachtiger P; Adamson A; Maclean WA; Kelshiker MA; Quint JK; Peters NS
    JMIR Public Health Surveill; 2021 Sep; 7(9):e30460. PubMed ID: 34298499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between multimorbidity and mortality in a cohort of patients admitted to hospital with COVID-19 in Scotland.
    Agrawal U; Azcoaga-Lorenzo A; Fagbamigbe AF; Vasileiou E; Henery P; Simpson CR; Stock SJ; Shah SA; Robertson C; Woolhouse M; Ritchie LD; Shiekh A; Harrison EM; Docherty AB; McCowan C
    J R Soc Med; 2022 Jan; 115(1):22-30. PubMed ID: 34672832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ
    Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland.
    Wood R; Thomson E; Galbraith R; Gribben C; Caldwell D; Bishop J; Reid M; Shah ASV; Templeton K; Goldberg D; Robertson C; Hutchinson SJ; Colhoun HM; McKeigue PM; McAllister DA
    Arch Dis Child; 2021 Dec; 106(12):1212-1217. PubMed ID: 33737319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.
    Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
    JAMA Netw Open; 2021 Aug; 4(8):e2122240. PubMed ID: 34448865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.